EQUITY RESEARCH / 2026 → 2029
Find a business worth researching. Understand what could drive growth, what could break the thesis, and how much success the entry price already assumes.
Research priorities reviewed 2026-09-23 · Editorial judgement, not a buy signal · Capital can be lost
SECTOR RESEARCH
Curated themes, not an industry index. Compare the business drivers first, then inspect individual companies and their entry valuations.
Compute, memory and optical links can benefit from larger AI deployments.
CRDO NBIS ALAB MU AMD AMAT ANET AVGO COHR AAOI
需关注事项: Organic revenue; customer concentration; cash after capex; product margins.
风险: AI spending is shared exposure: several tickers can depend on the same customers.
Electricity delivery and heat removal may constrain data-center expansion.
VRT ETN GEV
需关注事项: Organic orders; backlog conversion; factory capacity; cash conversion.
风险: Grid delays, capex cycles and high entry valuations.
Generation, components and fuel offer different exposure to nuclear investment.
BWXT CEG LEU
需关注事项: Funded contracts; outages; fuel capacity; maintenance and expansion capex.
风险: Permits, policy, project timing and financing; generators and fuel developers are not interchangeable.
Launch, communication and imaging require different paths to commercial scale.
RKLB ASTS PL RDW
需关注事项: Operational launches; paid usage; backlog conversion; funded cash runway.
风险: Launch failures, customer concentration and dilution.
Unmanned platforms and counter-drone systems may attract procurement.
AVAV KTOS
需关注事项: Funded backlog; production deliveries; organic margins; cash collections.
风险: Budget changes, program selection and contract execution losses.
Robotics, connected operations and testing can improve physical productivity.
SYM IOT TER
需关注事项: Installation economics; recurring usage; customer concentration; segment margins.
风险: Slow deployments and cyclical industrial or semiconductor budgets.
Diagnostics, surgical tools and drug discovery have distinct clinical and payment risks.
TEM HIMS RXRX ISRG NTRA GH TMDX
需关注事项: Reimbursed volumes; clinical milestones; collections; cash runway.
风险: Trial failure, reimbursement and regulation; do not value a drug pipeline like software.
Recurring tools support cloud operations, security and development.
NET CRWD DDOG
需关注事项: Retention; consumption; recurring revenue; GAAP margins; diluted shares.
风险: Competition, service incidents, stock compensation and entry multiples.
Advertising, cloud services and learning subscriptions can scale with engagement.
GOOGL DUOL APP
需关注事项: Paid retention; advertiser returns; cash flow; organic growth.
风险: Platform dependence, AI substitution, privacy rules and acquisition costs.
Useful technical performance must turn into repeat paid commercial demand.
IONQ QBTS RGTI QUBT
需关注事项: External orders; organic revenue; cash burn; reproducible technical milestones.
风险: Technical uncertainty, lumpy sales, acquisitions and dilution.
Higher energy density matters only if manufacturing becomes commercially viable.
ENVX
需关注事项: Qualified customers; manufacturing yield; unit cost; funded capacity.
风险: Qualification delays, yield failures and financing.
A broader customer relationship can support fee revenue and operating scale.
SOFI
需关注事项: Credit losses; capital adequacy; deposit costs; normalized earnings.
风险: Credit cycles and regulation; software sales multiples are inappropriate.
Coverage counts refer to this entire list and its current snapshots. Positive margin counts use only issuers with a known trailing-four-quarter net margin; a dash means unavailable. Different fiscal periods and business models are not directly comparable.
| 公司 | 研究优先级 | 风险 | 为什么研究它？ | 过时观察 |
|---|---|---|---|---|
| CRDOCredo TechnologyAI connectivity商业增长 | 研究优先级★★★★☆4 / 5 | 风险高4 / 5 | Higher bandwidth creates demand for efficient links inside AI clusters. 论点、风险与来源必须做对什么Broader customer adoption and sustained margins as connectivity speeds rise. 什么会破坏论点Customer concentration, competing optical designs or margin compression. 评估便宜之前Compare forward earnings and free cash flow with customer concentration. 超额回报情景10× needs sustained expansion well beyond the current customer base; valuation is unverified. Company newsroom lists FY2027 Q1 results and optical connectivity updates. 公司来源 ↗ 公司概况 → |
$150.99Stored close · 2026-10-30-50.1%From 252-session closing peak
63个交易日变化 -30.8%252个交易日变化 -12.0%
|
| NBISNebiusAI cloud商业增长 | 研究优先级★★★★☆4 / 5 | 风险极高5 / 5 | AI compute demand may support a larger specialist cloud business. 论点、风险与来源必须做对什么Commission capacity, fill it with paying customers and improve cash returns. 什么会破坏论点Power delays, underutilized GPUs, capex funding and shareholder dilution. 评估便宜之前Value cash flow after capex and debt; contracted demand is not earned revenue. 超额回报情景10× is an exceptional execution and funding scenario, not a base case. Q2 2026 results published August 12; AI cloud business and investment exposure disclosed. 公司来源 ↗ SEC指标未覆盖 |
—最近收盘价不可用 SEC指标未覆盖 |
| RKLBRocket LabSpace systems & launch商业增长 | 研究优先级★★★★☆4 / 5 | 风险极高5 / 5 | Launch services and spacecraft systems can serve growing commercial and defense demand. 论点、风险与来源必须做对什么Convert contracted backlog to cash and deliver the Neutron program. 什么会破坏论点Launch failures, development delays, acquisition integration and dilution. 评估便宜之前Separate organic sales, acquisition effects, capex and fully diluted shares. 超额回报情景10× requires much more than a successful launch; funding and entry valuation matter. Q2 2026 release reports growing revenue/backlog and an announced Iridium acquisition. 公司来源 ↗ 公司概况 → |
$54.73Stored close · 2026-10-30-63.6%From 252-session closing peak
63个交易日变化 -22.3%252个交易日变化 -17.3%
|
| ALABAstera LabsAI connectivity商业增长 | 研究优先级★★★★☆4 / 5 | 风险高4 / 5 | More complex AI systems need additional connectivity and switching products. 论点、风险与来源必须做对什么Scale Scorpio deployments and diversify product and customer revenue. 什么会破坏论点Customer concentration, competitive standards and a high entry valuation. 评估便宜之前Check revenue multiple, cash generation and stock-based compensation. 超额回报情景10× needs product expansion plus a defensible entry multiple; growth alone is insufficient. Q2 2026 release discusses Scorpio deployment and expansion of connectivity products. 公司来源 ↗ 公司概况 → |
$258.70Stored close · 2026-10-30-46.4%From 252-session closing peak
63个交易日变化 -19.4%252个交易日变化 +49.0%
|
| VRTVertivPower & cooling商业增长 | 研究优先级★★★★☆4 / 5 | 风险高4 / 5 | AI capacity needs power management and heat removal as well as chips. 论点、风险与来源必须做对什么Deliver liquid cooling and power capacity with healthy cash conversion. 什么会破坏论点Hyperscaler capex slowdown, manufacturing bottlenecks and pricing pressure. 评估便宜之前Check organic growth, working capital and free cash flow after capacity investment. 超额回报情景10× would require exceptional expansion from an already established business; entry valuation is unverified. July 29, 2026 release: Q2 sales rose 24%, including 18% organic growth. 公司来源 ↗ 公司概况 → |
$232.50Stored close · 2026-10-30-38.2%From 252-session closing peak
63个交易日变化 -11.6%252个交易日变化 +16.7%
|
| ETNEatonElectrical equipment对比企业 | 研究优先级★★★★☆4 / 5 | 风险重大3 / 5 | Grid expansion and data centers require electrical distribution and protection equipment. 论点、风险与来源必须做对什么Convert electrical backlog into deliveries while preserving margins. 什么会破坏论点Project delays, acquisition integration and a premium entry valuation. 评估便宜之前Separate organic sales from acquisitions; compare cash earnings with normalized capex. 超额回报情景Established industry comparison; 10× over 2–3 years is not a base case. Q2 2026 release: sales rose 21%, comprising 14% organic growth and 7% from acquisitions. 公司来源 ↗ 公司概况 → |
$366.07Stored close · 2026-11-02-20.4%From 252-session closing peak
63个交易日变化 -17.7%252个交易日变化 -4.4%
|
| GEVGE VernovaGrid & generation equipment对比企业 | 研究优先级★★★★☆4 / 5 | 风险高4 / 5 | Grid equipment, power generation and services address growing electricity requirements. 论点、风险与来源必须做对什么Convert Power and Electrification orders into profitable deliveries. 什么会破坏论点Long delivery cycles, wind losses, warranty costs and execution risk. 评估便宜之前Separate equipment and service economics; orders and customer advances are not earnings. 超额回报情景Industry comparison; a large backlog does not establish a 10× share-price opportunity. July 22, 2026 release: Q2 revenue rose 22%, or 12% organically, led by Power and Electrification. 公司来源 ↗ 公司概况 → |
$857.87Stored close · 2026-10-30-27.0%From 252-session closing peak
63个交易日变化 -14.8%252个交易日变化 +48.4%
|
| BWXTBWX TechnologiesNuclear components商业增长 | 研究优先级★★★★☆4 / 5 | 风险高4 / 5 | Nuclear components and services participate in defense and commercial reactor investment. 论点、风险与来源必须做对什么Deliver funded programs and expand manufacturing with disciplined cash returns. 什么会破坏论点Government concentration, project overruns and acquisition integration. 评估便宜之前Inspect funded backlog, contract margins and free cash flow after factory expansion. 超额回报情景10× needs exceptional per-share growth; nuclear exposure alone does not support it. August 3, 2026 release reports Q2 revenue of $901.6m and net income of $89.1m. 公司来源 ↗ 公司概况 → |
$130.70Stored close · 2026-10-30-45.2%From 252-session closing peak
63个交易日变化 -24.8%252个交易日变化 -38.8%
|
| ANETArista NetworksData-center networking对比企业 | 研究优先级★★★★☆4 / 5 | 风险高4 / 5 | Larger AI clusters require high-bandwidth Ethernet networking and software. 论点、风险与来源必须做对什么Convert AI networking deployments into sustained sales and customer diversification. 什么会破坏论点Hyperscaler concentration, competing architectures and valuation compression. 评估便宜之前Check customer acceptance terms, inventory and cash conversion alongside earnings. 超额回报情景Established networking comparison; no supported 10× forecast from demand growth alone. Investor materials link Q2 2026 results and cloud/AI networking presentations. 公司来源 ↗ 公司概况 → |
$168.86Stored close · 2026-10-30-22.1%From 252-session closing peak
63个交易日变化 -8.7%252个交易日变化 +4.2%
|
| ASTSAST SpaceMobileSatellite connectivity前沿技术 | 研究优先级★★★☆☆3 / 5 | 风险极高5 / 5 | Direct-to-phone satellite broadband could open a new connectivity market. 论点、风险与来源必须做对什么Launch and commission satellites, obtain approvals and convert coverage into paid service. 什么会破坏论点Launch or deployment failure, spectrum limits, funding needs and dilution. 评估便宜之前Model funded satellite deployment and paying usage, not only addressable market. 超额回报情景10× depends on network economics and funding; technical success alone is insufficient. Investor page describes the direct-to-cell network and links Q2 2026 filings. 公司来源 ↗ 公司概况 → |
$40.97Stored close · 2026-10-30-69.2%From 252-session closing peak
63个交易日变化 -35.5%252个交易日变化 -48.8%
|
| PLPlanet LabsEarth observation商业增长 | 研究优先级★★★☆☆3 / 5 | 风险高4 / 5 | Repeated Earth imagery can support government and commercial data subscriptions. 论点、风险与来源必须做对什么Renew contracts, expand analytics usage and convert bookings into cash. 什么会破坏论点Government budget concentration, competition and satellite replacement costs. 评估便宜之前Check recurring revenue quality, gross margin and cash flow after constellation costs. 超额回报情景10× needs durable cash-generating scale; no probability is assigned. Company investor overview; current valuation has not been validated. 公司来源 ↗ 公司概况 → |
$13.47Stored close · 2026-10-30-73.8%From 252-session closing peak
63个交易日变化 -37.4%252个交易日变化 +4.4%
|
| RDWRedwireSpace & defense商业增长 | 研究优先级★★★☆☆3 / 5 | 风险极高5 / 5 | Space infrastructure and defense platforms can benefit from program expansion. 论点、风险与来源必须做对什么Execute contracts, integrate acquired operations and convert backlog into cash. 什么会破坏论点Program delays, acquisition integration, debt and contract execution losses. 评估便宜之前Check organic growth, debt, working capital and cash conversion. 超额回报情景10× requires profitable expansion without excessive dilution or leverage. Investor page describes space/defense operations and links Q2 2026 results. 公司来源 ↗ 公司概况 → |
$8.39Stored close · 2026-10-30-67.6%From 252-session closing peak
63个交易日变化 -13.0%252个交易日变化 +6.9%
|
| TEMTempus AIHealthcare data商业增长 | 研究优先级★★★☆☆3 / 5 | 风险高4 / 5 | Diagnostics and clinical data may support a growing precision-medicine business. 论点、风险与来源必须做对什么Grow paid testing and data licensing with improving unit economics. 什么会破坏论点Reimbursement, privacy obligations, competition and integration costs. 评估便宜之前Separate diagnostics margins from data licensing and exclude acquisition-only growth. 超额回报情景10× requires durable per-share economics; the AI label is not a valuation model. Investor overview describes diagnostics and clinical-data products. 公司来源 ↗ 公司概况 → |
$72.22Stored close · 2026-10-30-19.6%From 252-session closing peak
63个交易日变化 +56.8%252个交易日变化 -18.7%
|
| HIMSHims & HersDigital health商业增长 | 研究优先级★★★☆☆3 / 5 | 风险极高5 / 5 | Digital distribution can broaden access to repeat-purchase healthcare services. 论点、风险与来源必须做对什么Improve retention and expand compliant product offerings with profitable acquisition costs. 什么会破坏论点Product regulation, supplier access, customer acquisition costs and churn. 评估便宜之前Check sustainable gross profit, retention and cash flow by product line. 超额回报情景10× would require durable expansion; a temporary product surge is insufficient. Company investor overview; SEC metrics are shown separately when covered. 公司来源 ↗ 公司概况 → |
$27.68Stored close · 2026-10-30-39.1%From 252-session closing peak
63个交易日变化 -10.2%252个交易日变化 -40.6%
|
| IONQIonQQuantum computing前沿技术 | 研究优先级★★★☆☆3 / 5 | 风险极高5 / 5 | Useful quantum systems could create demand for computing and related infrastructure. 论点、风险与来源必须做对什么Demonstrate paid deployments, repeat orders and useful technical performance. 什么会破坏论点Commercial utility may arrive late; cash burn, acquisitions and valuation can dominate. 评估便宜之前Separate organic revenue from acquired businesses; inspect cash burn and diluted shares. 超额回报情景10× is a tail scenario dependent on commercial adoption and entry valuation. Q2 2026 release discloses commercial deployments, losses and the SkyWater acquisition. 公司来源 ↗ 公司概况 → |
$30.04Stored close · 2026-10-30-58.3%From 252-session closing peak
63个交易日变化 -22.7%252个交易日变化 -50.8%
|
| SOFISoFi Technologies金融服务对比企业 | 研究优先级★★★☆☆3 / 5 | 风险高4 / 5 | Broader financial services may increase customer revenue and operating scale. 论点、风险与来源必须做对什么Grow durable fee income while controlling credit losses and acquisition costs. 什么会破坏论点Credit deterioration, funding costs, regulation and valuation compression. 评估便宜之前Check normalized earnings, credit losses, capital and tangible book value. 超额回报情景Included as a comparison business; 10×/100× is not an underwriting assumption. Company investor overview; current valuation is unverified in this screen. 公司来源 ↗ 公司概况 → |
$16.76Stored close · 2026-10-30-48.0%From 252-session closing peak
63个交易日变化 -7.0%252个交易日变化 -45.8%
|
| MUMicronMemory semiconductors对比企业 | 研究优先级★★★☆☆3 / 5 | 风险高4 / 5 | AI systems require additional memory capacity and bandwidth. 论点、风险与来源必须做对什么HBM execution and sustained returns on capacity investment through the cycle. 什么会破坏论点Memory oversupply, cyclical pricing, capex and export restrictions. 评估便宜之前Use mid-cycle earnings and cash flow; peak-cycle P/E can look misleadingly cheap. 超额回报情景Cycle comparison, not a validated 10× or 100× candidate. Investor materials discuss AI memory demand, HBM and capacity investment. 公司来源 ↗ 公司概况 → |
$833.59Stored close · 2026-11-02-31.3%From 252-session closing peak
63个交易日变化 -6.6%252个交易日变化 +272.1%
|
| AMDAdvanced Micro DevicesCompute semiconductors对比企业 | 研究优先级★★★☆☆3 / 5 | 风险高4 / 5 | Server processors and accelerators can participate in AI infrastructure spending. 论点、风险与来源必须做对什么Accelerator adoption, software execution and profitable server share growth. 什么会破坏论点Strong competition, customer concentration, supply constraints and export rules. 评估便宜之前Compare earnings and free cash flow with accelerator margins and dilution. 超额回报情景Comparison company; being smaller than a competitor does not establish 10× upside. Investor materials include Q2 2026 results and AI infrastructure partnerships. 公司来源 ↗ 公司概况 → |
$466.84Stored close · 2026-11-02-28.1%From 252-session closing peak
63个交易日变化 -10.0%252个交易日变化 +83.2%
|
| AMATApplied MaterialsChipmaking equipment对比企业 | 研究优先级★★★☆☆3 / 5 | 风险重大3 / 5 | More complex chips can increase demand for process equipment and services. 论点、风险与来源必须做对什么Technology transitions and sustained customer investment. 什么会破坏论点Semiconductor capex cycles, export restrictions and customer concentration. 评估便宜之前Compare mid-cycle cash earnings and services durability with the entry price. 超额回报情景Equipment-cycle comparison; 10×/100× is not an investment premise. Company investor relations; no claim that the current price is cheap. 公司来源 ↗ 公司概况 → |
$374.53Stored close · 2026-11-02-48.2%From 252-session closing peak
63个交易日变化 -31.5%252个交易日变化 +61.1%
|
| GOOGLAlphabetCloud & digital platforms对比企业 | 研究优先级★★★☆☆3 / 5 | 风险重大3 / 5 | Cloud growth and AI products may add to an established digital business. 论点、风险与来源必须做对什么Monetize AI while sustaining search economics and returns on capex. 什么会破坏论点Search disruption, antitrust remedies and heavy infrastructure spending. 评估便宜之前Check free cash flow after AI capex and the durability of search margins. 超额回报情景Established-business comparison; no supported 10×/100× thesis over 2–3 years. Alphabet investor materials; cheapness requires a verified entry valuation. 公司来源 ↗ SEC指标未覆盖 |
—最近收盘价不可用 SEC指标未覆盖 |
| CEGConstellation EnergyPower generation对比企业 | 研究优先级★★★☆☆3 / 5 | 风险高4 / 5 | Existing nuclear generation can supply reliable electricity to growing loads. 论点、风险与来源必须做对什么Sign attractive power contracts and operate the generation fleet reliably. 什么会破坏论点Outages, power-price changes, integration costs and regulatory intervention. 评估便宜之前Model contracted versus merchant power prices, maintenance capex and debt. 超额回报情景Established generator comparison; growth in electricity demand is not a 10× forecast. Investor materials describe a diversified generation fleet, nuclear operations and the Calpine transaction. 公司来源 ↗ 公司概况 → |
$262.38Stored close · 2026-10-30-31.4%From 252-session closing peak
63个交易日变化 -4.1%252个交易日变化 -34.6%
|
| AVGOBroadcomCustom compute & networking对比企业 | 研究优先级★★★☆☆3 / 5 | 风险高4 / 5 | Custom accelerators and networking may capture a share of AI infrastructure spending. 论点、风险与来源必须做对什么Scale custom compute programs and maintain recurring infrastructure software economics. 什么会破坏论点Customer concentration, leverage, program delays and multiple compression. 评估便宜之前Separate semiconductor cyclicality from software cash flow; include debt and dilution. 超额回报情景Large established-business comparison, not a validated 10× or 100× candidate. Company investor materials cover semiconductor solutions and infrastructure software. 公司来源 ↗ 公司概况 → |
$322.23Stored close · 2026-11-02-33.1%From 252-session closing peak
63个交易日变化 -22.9%252个交易日变化 -14.4%
|
| COHRCoherentOptical components商业增长 | 研究优先级★★★☆☆3 / 5 | 风险高4 / 5 | Faster data-center links increase the need for optical transceivers and photonics. 论点、风险与来源必须做对什么Expand high-speed optical capacity with sustained yields and margins. 什么会破坏论点Optical pricing pressure, customer concentration, debt and manufacturing execution. 评估便宜之前Check organic sales, leverage and cash flow after capacity spending. 超额回报情景10× needs durable per-share cash growth and a defensible entry valuation. August 12, 2026 release: fiscal Q4 revenue of $2.05bn, up 34% year on year. 公司来源 ↗ 公司概况 → |
$210.32Stored close · 2026-10-30-50.7%From 252-session closing peak
63个交易日变化 -27.0%252个交易日变化 +52.3%
|
| AAOIApplied OptoelectronicsOptical transceivers商业增长 | 研究优先级★★★☆☆3 / 5 | 风险极高5 / 5 | Optical links can benefit from increasing data-center bandwidth requirements. 论点、风险与来源必须做对什么Win repeat high-speed transceiver orders and improve production yields. 什么会破坏论点Customer concentration, product qualification delays, losses and funding needs. 评估便宜之前Check sustainable gross profit, capex and cash runway instead of extrapolating a small base. 超额回报情景A speculative manufacturing scale-up; volume growth may not translate into per-share value. Company investor materials describe fiber-optic access and data-center products. 公司来源 ↗ 公司概况 → |
$69.05Stored close · 2026-10-30-69.0%From 252-session closing peak
63个交易日变化 -37.3%252个交易日变化 +94.6%
|
| SYMSymboticWarehouse automation商业增长 | 研究优先级★★★☆☆3 / 5 | 风险极高5 / 5 | Warehouse automation can reduce handling costs and increase throughput. 论点、风险与来源必须做对什么Install systems on time and grow profitable recurring service revenue. 什么会破坏论点Customer concentration, installation delays and cost overruns. 评估便宜之前Check backlog cancellation terms, deployment margins and cash advances. 超额回报情景10× requires successful deployment at scale and attractive economics for shareholders. Company investor materials describe robotic warehouse systems and software. 公司来源 ↗ 公司概况 → |
$37.93Stored close · 2026-10-30-56.6%From 252-session closing peak
63个交易日变化 -17.3%252个交易日变化 -51.2%
|
| IOTSamsaraConnected operations商业增长 | 研究优先级★★★☆☆3 / 5 | 风险高4 / 5 | Fleet and industrial data can support recurring software for physical operations. 论点、风险与来源必须做对什么Expand paid deployments while sustaining retention and sales efficiency. 什么会破坏论点Competition, hardware costs, customer budgets and share-based compensation. 评估便宜之前Compare recurring revenue growth, retention and free cash flow after dilution. 超额回报情景10× is exceptional; recurring revenue alone does not justify any entry multiple. Company investor overview describes its Connected Operations platform. 公司来源 ↗ 公司概况 → |
$42.07Stored close · 2026-10-30-7.0%From 252-session closing peak
63个交易日变化 +13.3%252个交易日变化 +7.0%
|
| TERTeradyneTest equipment & robotics对比企业 | 研究优先级★★★☆☆3 / 5 | 风险高4 / 5 | More complex chips need testing, while industrial automation offers another demand channel. 论点、风险与来源必须做对什么Convert semiconductor test demand and improve robotics economics. 什么会破坏论点Semiconductor cycles, customer concentration and uneven robot adoption. 评估便宜之前Use segment-level and mid-cycle earnings; do not treat test revenue as robotics revenue. 超额回报情景Industrial comparison; no supported 10×/100× premise. Company investor materials cover semiconductor test and robotics businesses. 公司来源 ↗ 公司概况 → |
$274.37Stored close · 2026-10-30-43.3%From 252-session closing peak
63个交易日变化 -25.0%252个交易日变化 +57.7%
|
| AVAVAeroVironmentAutonomous defense systems商业增长 | 研究优先级★★★☆☆3 / 5 | 风险高4 / 5 | Demand for unmanned systems and counter-drone capabilities may support defense programs. 论点、风险与来源必须做对什么Scale funded production and convert contracts into cash. 什么会破坏论点Procurement delays, contract losses, integration risk and export restrictions. 评估便宜之前Separate organic growth from acquired operations and inspect funded backlog. 超额回报情景10× needs exceptional program expansion and cash generation; awards are not revenue. Investor page links fiscal Q1 2027 results dated September 9, 2026 and describes autonomous and counter-UAS systems. 公司来源 ↗ 公司概况 → |
$126.11Stored close · 2026-10-30-67.9%From 252-session closing peak
63个交易日变化 -20.8%252个交易日变化 -66.9%
|
| KTOSKratos DefenseDefense platforms & propulsion商业增长 | 研究优先级★★★☆☆3 / 5 | 风险极高5 / 5 | Affordable unmanned platforms, propulsion and space systems may win larger programs. 论点、风险与来源必须做对什么Move development projects into funded repeat production. 什么会破坏论点Programs may not scale; procurement timing, development spending and dilution. 评估便宜之前Distinguish prototypes and contract ceilings from funded production and earned revenue. 超额回报情景10× depends on program selection, funding and scalable margins. Company materials describe unmanned systems, propulsion, hypersonics and space capabilities. 公司来源 ↗ 公司概况 → |
$41.09Stored close · 2026-10-30-68.6%From 252-session closing peak
63个交易日变化 -16.5%252个交易日变化 -55.0%
|
| ISRGIntuitive SurgicalSurgical robotics对比企业 | 研究优先级★★★☆☆3 / 5 | 风险重大3 / 5 | An installed surgical robot base can support recurring instruments and service demand. 论点、风险与来源必须做对什么Grow procedures and system utilization with healthy recurring economics. 什么会破坏论点Hospital budgets, competition, regulatory issues and high entry expectations. 评估便宜之前Track procedure growth and recurring gross profit; distinguish placements from utilization. 超额回报情景Established medical technology comparison, not a validated 10× candidate. Company investor materials describe robotic-assisted surgery systems and recurring products. 公司来源 ↗ 公司概况 → |
$436.87Stored close · 2026-11-02-26.3%From 252-session closing peak
63个交易日变化 +18.6%252个交易日变化 -17.6%
|
| NTRANateraMolecular diagnostics商业增长 | 研究优先级★★★☆☆3 / 5 | 风险高4 / 5 | Clinical adoption of molecular testing may expand monitoring and diagnostic demand. 论点、风险与来源必须做对什么Grow reimbursed tests with improving cash collections and unit economics. 什么会破坏论点Reimbursement, clinical evidence, litigation and funding requirements. 评估便宜之前Compare recognized revenue with collections, test mix and cash burn. 超额回报情景10× requires clinical adoption and durable reimbursement economics. Investor materials describe cell-free DNA testing across clinical applications. 公司来源 ↗ 公司概况 → |
$414.30Stored close · 2026-10-30-5.0%From 252-session closing peak
63个交易日变化 +53.2%252个交易日变化 +114.9%
|
| GHGuardant HealthOncology diagnostics商业增长 | 研究优先级★★★☆☆3 / 5 | 风险极高5 / 5 | Blood-based oncology testing and screening may broaden the addressable patient population. 论点、风险与来源必须做对什么Grow reimbursed testing and reduce cash consumption as volumes scale. 什么会破坏论点Reimbursement, screening adoption, competition and continued losses. 评估便宜之前Inspect test-level economics, collections and funded runway; revenue growth alone is insufficient. 超额回报情景10× needs profitable adoption at scale; clinical usefulness is not proof of shareholder returns. July 30, 2026 release: Q2 revenue of $335.0m, up 44%, with continuing losses. 公司来源 ↗ 公司概况 → |
$178.80Stored close · 2026-10-30-4.5%From 252-session closing peak
63个交易日变化 +12.6%252个交易日变化 +147.4%
|
| TMDXTransMedicsOrgan transplant technology商业增长 | 研究优先级★★★☆☆3 / 5 | 风险高4 / 5 | Organ preservation and transplant logistics may increase the use of available donor organs. 论点、风险与来源必须做对什么Expand transplant volumes and logistics efficiency with sustainable margins. 什么会破坏论点Clinical or regulatory setbacks, logistics costs and hospital adoption. 评估便宜之前Separate technology and logistics economics; include aircraft and other capital needs. 超额回报情景10× needs repeatable clinical adoption and profitable capital-efficient expansion. Company investor materials describe the Organ Care System and transplant logistics. 公司来源 ↗ 公司概况 → |
$65.99Stored close · 2026-10-30-56.1%From 252-session closing peak
63个交易日变化 -19.1%252个交易日变化 -50.9%
|
| NETCloudflareCloud network & security商业增长 | 研究优先级★★★☆☆3 / 5 | 风险高4 / 5 | Security and developer services can grow on a shared global network. 论点、风险与来源必须做对什么Expand paid enterprise adoption while improving GAAP profitability. 什么会破坏论点Competition, service failures, network spending and share-based compensation. 评估便宜之前Reconcile adjusted profit with GAAP losses, cash flow and diluted shares. 超额回报情景10× requires sustained adoption plus entry-multiple discipline. August 6, 2026 release reports revenue growth alongside a GAAP operating loss. 公司来源 ↗ 公司概况 → |
$280.70Stored close · 2026-10-30-22.2%From 252-session closing peak
63个交易日变化 -0.7%252个交易日变化 +23.4%
|
| CRWDCrowdStrike网络安全对比企业 | 研究优先级★★★☆☆3 / 5 | 风险高4 / 5 | Security platform consolidation may increase recurring customer spending. 论点、风险与来源必须做对什么Sustain retention, cross-selling and reliable service delivery. 什么会破坏论点Service incidents, liability, competition and elevated valuation. 评估便宜之前Track recurring revenue, renewal concessions and free cash flow after dilution. 超额回报情景Established software comparison; no supported 10×/100× thesis. Company investor materials describe the Falcon cybersecurity platform. 公司来源 ↗ 公司概况 → |
$241.81Stored close · 2026-11-02-13.3%From 252-session closing peak
63个交易日变化 +14.5%252个交易日变化 +79.6%
|
| DDOGDatadogCloud observability商业增长 | 研究优先级★★★☆☆3 / 5 | 风险高4 / 5 | More complex cloud and AI workloads require monitoring and security tools. 论点、风险与来源必须做对什么Expand paid usage while maintaining retention and cash efficiency. 什么会破坏论点Cloud-spend optimization, competition and share-based compensation. 评估便宜之前Inspect consumption trends, customer concentration and per-share cash economics. 超额回报情景10× depends on exceptional sustained growth and a reasonable entry price. Company publishes Q2 2026 results and materials on observability and security. 公司来源 ↗ 公司概况 → |
$235.27Stored close · 2026-10-30-19.8%From 252-session closing peak
63个交易日变化 -14.0%252个交易日变化 +50.8%
|
| DUOLDuolingoDigital education商业增长 | 研究优先级★★★☆☆3 / 5 | 风险高4 / 5 | A broad learning audience can support paid subscriptions and additional courses. 论点、风险与来源必须做对什么Convert engagement into retained paid users without excessive acquisition costs. 什么会破坏论点AI competition, weaker monetization, churn and platform dependence. 评估便宜之前Compare bookings, recognized revenue, paid retention and free cash flow. 超额回报情景10× needs durable monetization, not just growth in free users. Company investor materials describe its learning platform and subscription business. 公司来源 ↗ 公司概况 → |
$131.59Stored close · 2026-10-30-51.4%From 252-session closing peak
63个交易日变化 -3.1%252个交易日变化 -51.8%
|
| APPAppLovinAdvertising software商业增长 | 研究优先级★★★☆☆3 / 5 | 风险极高5 / 5 | Better ad targeting and measurement can attract advertiser spending. 论点、风险与来源必须做对什么Demonstrate repeat advertiser returns and diversify demand profitably. 什么会破坏论点Platform policy, privacy rules, advertiser concentration and valuation. 评估便宜之前Check organic sales, cash quality, leverage and dependence on external platforms. 超额回报情景10× is an exceptional outcome; recent operating growth is not a return forecast. Company investor materials describe advertising software and its performance platform. 公司来源 ↗ 公司概况 → |
$228.85Stored close · 2026-11-02-68.8%From 252-session closing peak
63个交易日变化 -45.5%252个交易日变化 -63.1%
|
| QBTSD-Wave QuantumQuantum computing前沿技术 | 研究优先级★★☆☆☆2 / 5 | 风险极高5 / 5 | Quantum optimization and computing could find repeat commercial uses. 论点、风险与来源必须做对什么Turn pilot activity into repeat orders and revenue that covers growing costs. 什么会破坏论点Lumpy system sales, limited commercial demand, cash burn and competing approaches. 评估便宜之前Value recognized recurring demand separately from bookings and one-off system sales. 超额回报情景10× remains a speculative adoption scenario; a technology headline is not proof. Q2 2026 financial results disclose operating investment and losses. 公司来源 ↗ 公司概况 → |
$10.65Stored close · 2026-10-30-71.3%From 252-session closing peak
63个交易日变化 -46.7%252个交易日变化 -68.9%
|
| RGTIRigetti ComputingQuantum computing前沿技术 | 研究优先级★★☆☆☆2 / 5 | 风险极高5 / 5 | Superconducting quantum processors may benefit if scalable useful systems emerge. 论点、风险与来源必须做对什么Demonstrate reliable systems and convert technical milestones into paying demand. 什么会破坏论点Hardware roadmap misses, competing architectures, cash burn and dilution. 评估便宜之前Check system revenue, cash runway and financing needs before revenue multiples. 超额回报情景10× is a tail outcome with technical and commercial failure risk. Investor overview describes the full-stack superconducting platform and Q2 2026 reporting. 公司来源 ↗ 公司概况 → |
$11.25Stored close · 2026-10-30-74.6%From 252-session closing peak
63个交易日变化 -29.8%252个交易日变化 -71.5%
|
| RXRXRecursionDrug discovery前沿技术 | 研究优先级★★☆☆☆2 / 5 | 风险极高5 / 5 | Computational discovery may produce valuable medicines and partnerships. 论点、风险与来源必须做对什么Positive clinical evidence and meaningful partner milestones. 什么会破坏论点Trial failure, regulatory setbacks, cash burn and dilution. 评估便宜之前Use risk-adjusted clinical programs and cash runway, not a software revenue multiple. 超额回报情景Binary clinical outcomes make 10× scenarios highly uncertain; capital loss is possible. Company describes a clinical-stage pipeline and AI-enabled drug discovery platform. 公司来源 ↗ 公司概况 → |
$4.03Stored close · 2026-10-30-28.7%From 252-session closing peak
63个交易日变化 +26.7%252个交易日变化 -31.3%
|
| ENVXEnovixBattery technology前沿技术 | 研究优先级★★☆☆☆2 / 5 | 风险极高5 / 5 | Higher energy-density batteries may win demanding device applications. 论点、风险与来源必须做对什么Customer qualification, manufacturing yield and profitable volume production. 什么会破坏论点Production yield, delayed qualification, cash burn and funding needs. 评估便宜之前Model yield, unit cost and funded capacity before extrapolating design wins. 超额回报情景10× requires successful industrial scaling; prototype performance is insufficient. Company investor overview; manufacturing and qualification remain key diligence topics. 公司来源 ↗ 公司概况 → |
$3.15Stored close · 2026-10-30-74.2%From 252-session closing peak
63个交易日变化 -25.4%252个交易日变化 -73.2%
|
| LEUCentrus EnergyNuclear fuel前沿技术 | 研究优先级★★☆☆☆2 / 5 | 风险极高5 / 5 | Domestic enrichment and advanced-reactor fuel may become important supply constraints. 论点、风险与来源必须做对什么Secure funded demand and scale enrichment capacity at viable unit costs. 什么会破坏论点Policy dependence, supply restrictions, construction funding and timing of reactor demand. 评估便宜之前Separate existing fuel supply economics from still-to-be-funded enrichment expansion. 超额回报情景A speculative scaling scenario; funding and dilution can overwhelm operating progress. Company materials describe nuclear fuel supply, enrichment technology and HALEU capabilities. 公司来源 ↗ 公司概况 → |
$103.29Stored close · 2026-10-30-73.1%From 252-session closing peak
63个交易日变化 -44.1%252个交易日变化 -73.6%
|
| QUBTQuantum Computing Inc.Quantum & photonics前沿技术 | 研究优先级★☆☆☆☆1 / 5 | 风险极高5 / 5 | Photonic products and foundry services may develop commercial demand. 论点、风险与来源必须做对什么Verify repeat external orders, recognized revenue and production economics. 什么会破坏论点Unproven commercial scale, execution, cash consumption and dilution. 评估便宜之前Require customer and revenue evidence before applying a sales multiple. 超额回报情景No support for a 100× investment thesis; commercial evidence must come first. Company investor relations; valuation and sustained commercial scale require further diligence. 公司来源 ↗ 公司概况 → |
$6.60Stored close · 2026-10-30-60.5%From 252-session closing peak
63个交易日变化 -24.5%252个交易日变化 -57.5%
|
没有公司符合这些筛选条件。请放宽阈值或移除条件。
SCENARIO LAB
Start with a dated market cap from a trusted source. These are your assumptions, not live company data. See how dilution and the future valuation multiple change the sales required for a share-price return.
请输入正的市值、年收入和市销率；股份增长必须为0–1000%。缺失或无效输入将不产生估算。
基于您输入的说明性情景——非目标价格
Future equity market cap = current cap × share-price multiple × (1 + new shares / current shares). Required annual sales = future equity cap / assumed equity price-to-sales. Revenue CAGR = (required sales / current annual sales)^(1 / years) − 1. The model excludes dividends, taxes and currency effects. It does not price bankruptcy risk or establish that a future sales multiple is reasonable. Clinical-stage biotechnology and banks need different valuation models.
Stars rank the order of further research for this particular 2–3 year brief. They are editorial assessments, not model scores, return forecasts or buy recommendations. The same rating is a tie; row order within it is not a finer ranking.
★★★★★ requires a verified attractive entry valuation and a complete thesis review; no company receives it here. ★★★★☆ prioritizes a visible commercial catalyst. ★★★☆☆ means material questions remain. ★★☆☆☆ needs technical, clinical or commercial milestones. ★☆☆☆☆ needs stronger revenue evidence before a return thesis. Reviews expire after 90 days.
Risk describes business and financing uncertainty on an editorial 1–5 scale. 3 is substantial, 4 high and 5 extreme. It is not a loss probability, and all rows carry valuation risk.
SEC facts and daily price history reuse the existing FinEdg data store. SEC snapshot as of 2026-11-04; page observed 2026-11-04 18:34 UTC. A covered issuer can still have missing metrics.
Revenue growth compares the latest supported quarter with a year earlier. Net margin uses four matched quarters. A missing value stays unavailable. A stored close must be no more than seven calendar days old; it is not a live quote. Price changes compare closes 63 or 252 stored sessions apart; they require 64 or 253 valid observations, respectively. They exclude dividends and are historical, not return forecasts. ROE uses trailing-four-quarter net income over current reported equity; EPS acceleration is the change in year-on-year EPS growth, in percentage points. Sorting is descending with missing observations last, and does not rank cheapness. The drawdown compares that close with the maximum of the last 252 stored daily closes, not total return or intrinsic value.
Price provenance: Daily EOD closes from the BibaMoney price store (splits reflected, cash dividends not).
Algoseek API access has been checked separately. Its feed is not the source of this public table; display rights and integration remain unconfirmed. No Algoseek observations are exposed here.
Not verified in this view. A 13F reports quarterly holdings, not a real-time trade tape. Purchases require comparison of share counts across matched filings, with amendments and corporate actions handled. Short positions are omitted. The Q2 2026 reporting deadline was August 14, 2026. SEC Form 13F guidance ↗
These 44 names are a curated research list, not a screen proving capitalization below $10bn. A lower stock price, a drawdown, or a smaller capitalization than a competitor does not establish a bargain.